SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs & Pharmaceuticals informs about outcome of board meeting

22 Jan 2022 Evaluate
Welcure Drugs & Pharmaceuticals has informed that the Board of Directors of the Company in their meeting held today, Saturday, 22nd January, 2022 at 11:30 am and concluded at 12:25 pm, approved the Un-Audited Financial Results for the quarter and nine months ended December 31, 2021 along with Limited Review Report for the said period. The Un-Audited Financial Results for the Quarter and nine months ended December 31, 2021 will be intimated separately.

The above information is a part of company’s filings submitted to BSE.

Welcure Drugs&Pharma Share Price

0.31 0.00 (0.00%)
12-May-2026 09:49 View Price Chart
Peers
Company Name CMP
Redington 214.55
Adani Enterprises 2476.95
Amrapali Industries 18.49
Rashi Peripheral 524.50
PDS 288.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×